Volpara Health, a Lunit company based in New Zealand, announced a $7.3 million contract with the U.S. Defense Health Agency (DHA) to implement its Patient Hub platform to improve mammography reporting, risk assessment, and patient tracking within the military health system.

The five-year agreement aims to enhance breast cancer screening and management services for active-duty military members, retirees, and their families. The DHA oversees healthcare for roughly 9.6 million individuals across branches of the U.S. military.

Patient Hub will integrate into DHA’s facilities, streamlining breast health management by automating appointment scheduling, risk assessments, and mammogram tracking. The platform’s features will allow healthcare providers within the DHA to deliver more efficient, personalized care by reducing administrative tasks and ensuring adherence to breast health guidelines.
"Working with the Defense Health Agency is a tremendous opportunity to improve healthcare for those who serve our nation," said Teri Thomas, CEO of Volpara and CBO of Lunit. "Achieving certification to meet the Department of Defense's rigorous security standards demonstrates our commitment to patient care and data security. We look forward to providing state-of-the-art solutions that make a difference in breast health outcomes."

Lunit acquired Volpara in May for $193 million.

Volpara’s partnership with the DHA builds on a long-standing relationship; previous versions of its mammography reporting software have supported U.S. military healthcare facilities since 1990. The company’s AI-powered technology, utilized in over 2,000 facilities worldwide, focuses on early cancer detection by analyzing breast tissue density and optimizing mammogram procedures.

Women's Health Homepage